Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine A vs Cyclophosphamide for Lupus Nephritis
NCT00976300Phase 2Completed
- Sponsor
- Kennedy Institute of Rheumatology
- Start
- Jan 2002
- Primary completion
- May 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine in lupus nephritis (LN), sponsored by Kennedy Institute of Rheumatology. Started Jan 2002; status: completed.
02
Drugs
cyclosporine
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT00976300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00976300.